HER2 Support Group Forums - View Single Post - Study shows valuable role of Mammostrat in assessing ER+ postmenopausal breast cancer

News · 06-03-2012, 11:23 PM

GE Healthcare today announced results from the Tamoxifen and Exemestane Adjuvant Multinational (TEAM) Trial at the 2012 Annual Meeting of the American Society of Clinical Oncology.

More...

06-03-2012, 11:23 PM	#1
News Senior Member Join Date: Oct 2007 Posts: 18,987	Study shows valuable role of Mammostrat in assessing ER+ postmenopausal breast cancer GE Healthcare today announced results from the Tamoxifen and Exemestane Adjuvant Multinational (TEAM) Trial at the 2012 Annual Meeting of the American Society of Clinical Oncology. More...